USADA's chief science officer publishes editorial on anti-dope testing in sport: History and science

Lance Armstrong's doping scandal may be considered by U.S. Anti-Doping Agency (USADA) as "more extensive than any previously revealed in professional sports history," but a new editorial in The FASEB Journal by USADA's Larry D. Bowers shows that it is clearly not the first. From early athletes who used rat poison and heroin to fight fatigue to modern Olympians who perform under the ever-present shadow of high tech hormones, stimulants and steroids, this editorial lays out both the history and the science behind athletic "doping" scandals. Bowers traces modern antidoping regulation to tragic accidents such as the death of British cyclist Tommy Simpson in the 1967 Tour de France, a race then notorious as a pharmaceutical free-for-all.

"With a steady stream of new therapeutic agents—from stimulants to steroids to protein hormones—with potential for abuse in sport entering the marketplace, antidoping scientists and collaborators are continually developing new approaches for detection of prohibited substances and methods," wrote Bowers in the editorial. "The challenge of developing and validating methods for the long list of prohibited substances and methods is daunting, requiring analytical skills, a thorough understanding of and pharmacokinetics, and an appreciation of and endocrinology."

In the editorial, Bowers describes how doping athletes have progressively employed more sophisticated techniques and tools to avoid detection by increasingly comprehensive tests. This leads to his coverage of emerging areas of medicine which may lead to entirely new classes of performance enhancers, such as . He also covers the various actions taken by legislators and athletic committees to ensure fair competition. The editorial is available to the public at no charge and can be read in its entirety at http://www.fasebj.org/content/26/10/3933.full.

"We often think of medical breakthroughs as bringing cures to those who are sick," said Gerald Weissmann, MD, editor-in-chief of The , "but for some who are in peak physical condition, these breakthroughs offer a way to extend the human body beyond its limits. In many cases, however, these temporary gains in physical performance carry hidden health risks - such as heart disease or cancer - that strike after the performance years have passed."

More information: The editorial is available to the public at no charge and can be read in its entirety at www.fasebj.org/content/26/10/3933.full

add to favorites email to friend print save as pdf

Related Stories

Anti-doping expert warns cheating athletes

Sep 15, 2011

Professor David Cowan, Director of the Drug Control Center at King’s College London, has warned athletes who take prohibited performance-enhancing substances that the London 2012 Olympic and Paralympic Games will be ...

Time to address stimulant abuse on our campuses

Sep 06, 2011

Universities and colleges need to do more to protect young adults from the dangers of illicit stimulant use and to educate them about harms, argue the authors of an editorial in CMAJ (Canadian Medical Association Journal).

Recommended for you

Doctor behind 'free radical' aging theory dies

19 hours ago

Dr. Denham Harman, a renowned scientist who developed the most widely accepted theory on aging that's now used to study cancer, Alzheimer's disease and other illnesses, has died in Nebraska at age 98.

Mexican boy who had massive tumor recovering

Nov 25, 2014

An 11-year-old Mexican boy who had pieces of a massive tumor removed and who drew international attention after U.S. officials helped him get treatment in the southwestern U.S. state of New Mexico is still recovering after ...

New medical device to make the mines safer

Nov 21, 2014

Dehydration can be a serious health issue for Australia's mining industry, but a new product to be developed with input from Flinders University's Medical Device Partnering Program (MDPP) is set to more effectively ...

US family gets $6.75 million in Botox case

Nov 20, 2014

A New York couple who said Botox treatment of their son's cerebral palsy left him with life-threatening complications and sued its manufacturer won a $6.75 million verdict from a federal jury on Thursday.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.